Clinical Trials

The James Cancer Center Columbus, OH

open for enrollment

Ph 1b / Ph 2 Evaluating Gem/ Docetaxel W/ or WO/ Olaratumab in the TX of Adv Soft Tissue Sarcoma

Protocol: OSU-15300

Full Title

A Phase 1b (Open-Label) / Phase 2 (Randomized,Double-Blinded) Study Evaluating Gemcitabine and Docetaxel With or Without Olaratumab in the Treatment of Advanced Soft Tissue Sarcoma